Due to the fact Pirfenidone is metabolised with the CYP1A2 enzyme pathway, any drug which inhibits this enzyme is likely to precipitate the toxicity of pirfenidone: concomitant therapy should be to be avoided. lonapegsomatropin will decrease the extent or effect of pirfenidone by influencing hepatic enzyme CYP1A2 metabolism. givosiran will https://marcolxjwg.bcbloggers.com/29213724/an-unbiased-view-of-gsk8612